Answers are grounded in this paper and cite their sources.
Analysis demonstrates SGLT2 inhibitors improve kidney function in pediatric chronic kidney disease patients, suggesting therapeutic benefits.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Olatise et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: